blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1973883

EP1973883 - NOVEL COMPOUNDS AND METHODS FOR THEIR PRODUCTION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  17.05.2013
Database last updated on 03.09.2024
Most recent event   Tooltip18.07.2014Lapse of the patent in a contracting state
New state(s): HU		published on 20.08.2014  [2014/34]
Applicant(s)For all designated states
Bristol-Myers Squibb Company
Route 206 and Province Line Road
Princeton, NJ 08543 / US
[N/P]
Former [2010/38]For all designated states
Bristol-Myers Squibb Company
Route 206 and Province Line Road P.O. Box 4000
Princeton, NJ 08543-4000 / US
Former [2008/40]For all designated states
Biotica Technology Limited
Chesterford Research Park, Little Chesterford Nr Saffron Walden
Essex CB10 1XL / GB
Inventor(s)01 / MARTIN, Christine
Biotica Technology Limited
Chesterford Research Park
Little Chesterford
Nr Saffron Walden, Essex CB10 1XL / GB
 [2012/28]
Former [2008/40]01 / MARTIN, Christine
Biotica Technology Limited Chesterford Research Park Little Chesterford
Nr Saffron Walden, Essex CB10 1XL / GB
Representative(s)Riedl, Peter
Patentanwälte
Reitstötter, Kinzebach & Partner (GbR)
Sternwartstrasse 4
81679 München / DE
[N/P]
Former [2012/28]Riedl, Peter
Patentanwälte Reitstötter, Kinzebach & Partner (GbR) Sternwartstrasse 4
81679 München / DE
Former [2010/35]Riedl, Peter
Patentanwälte Reitstötter, Kinzebach & Partner (GbR) Sternwartstrasse 4
81679 München / DE
Former [2008/40]Teuten, Andrew John
Sagittarius Intellectual Property Consultants Ltd Taylor House 39 High Street
Marlow, Bucks. SL7 1AF / GB
Application number, filing date07824891.109.11.2007
[2008/40]
WO2007GB50679
Priority number, dateGB2006002234209.11.2006         Original published format: GB 0622342
GB2007002087524.10.2007         Original published format: GB 0720875
[2008/40]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2008056188
Date:15.05.2008
Language:EN
[2008/20]
Type: A2 Application without search report 
No.:EP1973883
Date:01.10.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 15.05.2008 takes the place of the publication of the European patent application.
[2008/40]
Type: B1 Patent specification 
No.:EP1973883
Date:11.07.2012
Language:EN
[2012/28]
Search report(s)International search report - published on:EP31.07.2008
ClassificationIPC:C07D225/06, A61K31/395, A61P35/00
[2008/40]
CPC:
C07D225/06 (EP,KR,US); A61K31/395 (KR); A61P25/00 (EP);
A61P25/28 (EP); A61P31/10 (EP); A61P33/06 (EP);
A61P35/00 (EP,KR); A61P37/00 (EP); A61P43/00 (EP);
A61P9/00 (EP); Y02A50/30 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/40]
TitleGerman:NEUARTIGE VERBINDUNGEN UND VERFAHREN ZU DEREN HERSTELLUNG[2008/40]
English:NOVEL COMPOUNDS AND METHODS FOR THEIR PRODUCTION[2008/40]
French:NOUVEAUX COMPOSÉS ET LEURS PROCÉDÉS DE PRODUCTION[2008/40]
Entry into regional phase27.03.2008National basic fee paid 
27.03.2008Designation fee(s) paid 
27.03.2008Examination fee paid 
Examination procedure27.03.2008Amendment by applicant (claims and/or description)
27.03.2008Examination requested  [2008/40]
15.06.2009Despatch of a communication from the examining division (Time limit: M06)
02.02.2010Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
12.04.2010Reply to a communication from the examining division
22.09.2010Despatch of a communication from the examining division (Time limit: M04)
31.01.2011Reply to a communication from the examining division
10.08.2011Despatch of a communication from the examining division (Time limit: M04)
16.09.2011Reply to a communication from the examining division
07.12.2011Communication of intention to grant the patent
16.04.2012Fee for grant paid
16.04.2012Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  15.06.2009
Opposition(s)12.04.2013No opposition filed within time limit [2013/25]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
12.04.2010Request for further processing filed
12.04.2010Full payment received (date of receipt of payment)
Fees paidRenewal fee
06.11.2009Renewal fee patent year 03
12.11.2010Renewal fee patent year 04
14.11.2011Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU09.11.2007
AT11.07.2012
BE11.07.2012
CY11.07.2012
CZ11.07.2012
DK11.07.2012
EE11.07.2012
FI11.07.2012
LT11.07.2012
LV11.07.2012
MT11.07.2012
NL11.07.2012
PL11.07.2012
RO11.07.2012
SE11.07.2012
SI11.07.2012
SK11.07.2012
TR11.07.2012
BG11.10.2012
GR12.10.2012
IE09.11.2012
LU09.11.2012
IS11.11.2012
PT12.11.2012
CH30.11.2012
LI30.11.2012
MC30.11.2012
[2014/34]
Former [2014/27]AT11.07.2012
BE11.07.2012
CY11.07.2012
CZ11.07.2012
DK11.07.2012
EE11.07.2012
FI11.07.2012
LT11.07.2012
LV11.07.2012
MT11.07.2012
NL11.07.2012
PL11.07.2012
RO11.07.2012
SE11.07.2012
SI11.07.2012
SK11.07.2012
TR11.07.2012
BG11.10.2012
GR12.10.2012
IE09.11.2012
LU09.11.2012
IS11.11.2012
PT12.11.2012
CH30.11.2012
LI30.11.2012
MC30.11.2012
Former [2014/21]AT11.07.2012
BE11.07.2012
CY11.07.2012
CZ11.07.2012
DK11.07.2012
EE11.07.2012
FI11.07.2012
LT11.07.2012
LV11.07.2012
MT11.07.2012
NL11.07.2012
PL11.07.2012
RO11.07.2012
SE11.07.2012
SI11.07.2012
SK11.07.2012
TR11.07.2012
BG11.10.2012
GR12.10.2012
IE09.11.2012
IS11.11.2012
PT12.11.2012
CH30.11.2012
LI30.11.2012
MC30.11.2012
Former [2013/51]AT11.07.2012
BE11.07.2012
CY11.07.2012
CZ11.07.2012
DK11.07.2012
EE11.07.2012
FI11.07.2012
LT11.07.2012
LV11.07.2012
MT11.07.2012
NL11.07.2012
PL11.07.2012
RO11.07.2012
SE11.07.2012
SI11.07.2012
SK11.07.2012
BG11.10.2012
GR12.10.2012
IE09.11.2012
IS11.11.2012
PT12.11.2012
CH30.11.2012
LI30.11.2012
Former [2013/47]AT11.07.2012
BE11.07.2012
CY11.07.2012
CZ11.07.2012
DK11.07.2012
EE11.07.2012
FI11.07.2012
LT11.07.2012
LV11.07.2012
NL11.07.2012
PL11.07.2012
RO11.07.2012
SE11.07.2012
SI11.07.2012
SK11.07.2012
BG11.10.2012
GR12.10.2012
IE09.11.2012
IS11.11.2012
PT12.11.2012
CH30.11.2012
LI30.11.2012
Former [2013/34]AT11.07.2012
BE11.07.2012
CY11.07.2012
CZ11.07.2012
DK11.07.2012
EE11.07.2012
FI11.07.2012
LT11.07.2012
LV11.07.2012
NL11.07.2012
PL11.07.2012
RO11.07.2012
SE11.07.2012
SI11.07.2012
SK11.07.2012
BG11.10.2012
GR12.10.2012
IS11.11.2012
PT12.11.2012
CH30.11.2012
LI30.11.2012
Former [2013/33]AT11.07.2012
BE11.07.2012
CY11.07.2012
CZ11.07.2012
DK11.07.2012
EE11.07.2012
FI11.07.2012
LT11.07.2012
LV11.07.2012
NL11.07.2012
PL11.07.2012
RO11.07.2012
SE11.07.2012
SI11.07.2012
SK11.07.2012
GR12.10.2012
IS11.11.2012
PT12.11.2012
CH30.11.2012
LI30.11.2012
Former [2013/23]AT11.07.2012
BE11.07.2012
CY11.07.2012
CZ11.07.2012
DK11.07.2012
EE11.07.2012
FI11.07.2012
LT11.07.2012
LV11.07.2012
NL11.07.2012
PL11.07.2012
RO11.07.2012
SE11.07.2012
SI11.07.2012
SK11.07.2012
GR12.10.2012
IS11.11.2012
PT12.11.2012
Former [2013/22]AT11.07.2012
BE11.07.2012
CY11.07.2012
CZ11.07.2012
DK11.07.2012
EE11.07.2012
FI11.07.2012
LT11.07.2012
LV11.07.2012
NL11.07.2012
PL11.07.2012
SE11.07.2012
SI11.07.2012
GR12.10.2012
IS11.11.2012
PT12.11.2012
Former [2013/21]AT11.07.2012
BE11.07.2012
CY11.07.2012
DK11.07.2012
FI11.07.2012
LT11.07.2012
LV11.07.2012
NL11.07.2012
PL11.07.2012
SE11.07.2012
SI11.07.2012
GR12.10.2012
IS11.11.2012
PT12.11.2012
Former [2013/15]AT11.07.2012
BE11.07.2012
CY11.07.2012
FI11.07.2012
LT11.07.2012
LV11.07.2012
NL11.07.2012
PL11.07.2012
SE11.07.2012
SI11.07.2012
GR12.10.2012
IS11.11.2012
PT12.11.2012
Former [2013/13]AT11.07.2012
BE11.07.2012
CY11.07.2012
FI11.07.2012
LT11.07.2012
LV11.07.2012
PL11.07.2012
SE11.07.2012
SI11.07.2012
GR12.10.2012
IS11.11.2012
PT12.11.2012
Former [2013/12]AT11.07.2012
BE11.07.2012
CY11.07.2012
FI11.07.2012
LT11.07.2012
LV11.07.2012
PL11.07.2012
SE11.07.2012
SI11.07.2012
GR12.10.2012
IS11.11.2012
Former [2013/11]AT11.07.2012
BE11.07.2012
CY11.07.2012
FI11.07.2012
LT11.07.2012
LV11.07.2012
PL11.07.2012
SI11.07.2012
GR12.10.2012
IS11.11.2012
Former [2013/10]AT11.07.2012
BE11.07.2012
CY11.07.2012
FI11.07.2012
LT11.07.2012
IS11.11.2012
Former [2013/09]AT11.07.2012
BE11.07.2012
FI11.07.2012
LT11.07.2012
Former [2013/08]AT11.07.2012
BE11.07.2012
LT11.07.2012
Former [2013/07]AT11.07.2012
Cited inInternational search[X]WO2005061461  (KYOWA HAKKO KOGYO KK [JP], et al) [X] 1-3,5,7-9,11,16,18-21 * Excluded by provisos (ii) /(iii); page 21 *;
 [PX]WO2007001049  (KYOWA HAKKO KOGYO KK [JP], et al) [PX] 1-99 * pages 5,36; examples 13-16; compounds 15-19 *;
 [XP]WO2007074347  (BIOTICA TECH LTD [GB], et al) [XP] 1-38,61 * Compound TAN-420E, excluded by proviso (i); page 5; compound 11 *;
 [E]EP1897871  (KYOWA HAKKO KOGYO KK [JP]) [E] 1-99 * paragraph [0008]; examples 13-16; table 1; compounds 15-19 *;
 [X]  - STEAD P ET AL, "Discovery of novel ansamycins possessing potent inhibitory activity in a Cell-based Oncostatin M signalling assay", JOURNAL OF ANTIBIOTICS, JAPAN ANTIBIOTICS RESEARCH ASSOCIATION, TOKYO, JP, (20000701), vol. 53, no. 7, ISSN 0021-8820, pages 657 - 663, XP002988238 [X] 1,38,61 * Compounds 1,2 and 3 excluded by proviso (ii) Results and Discussion *
 [X]  - LI M G ET AL, "Isolation and Structure Elucidation of Autolytimycin, A new Compound Produced by Streptomyces Autolyticus JX-47", CHINESE CHEMICAL LETTERS, XX, XX, (20010101), vol. 12, no. 10, ISSN 1001-8417, pages 903 - 906, XP002988236 [X] 1,38,61 * the whole document *
 [X]  - TAKATSU T ET AL, "Reblastatin, a novel benzenoid ansamycin-type cell cacle inhibitor", JOURNAL OF ANTIBIOTICS, JAPAN ANTIBIOTICS RESEARCH ASSOCIATION, TOKYO, JP, (20001101), vol. 53, no. 11, ISSN 0021-8820, pages 1310 - 1312, XP002988237 [X] 1-38,61 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.